The American College of Radiology (ACR) issued a statement regarding the WISDOM Breast Cancer Screening Trial results, which were published in JAMA. The ACR expressed appreciation for the study's aim to explore risk-based breast cancer screening as an alternative to annual mammography. However, they criticized the study design and results, stating they do not provide sufficient evidence to warrant changes to existing screening policies. The ACR emphasizes its commitment to regularly reviewing studies and data to update breast cancer screening guidelines. For more information or to speak with an expert, the ACR Public Affairs can be contacted.
Fri, 12 Dec 2025 15:45:00 GMT | Newswise